Cross-talk between angiotensin II and interleukin-6-induced signaling through Stat3 transcription factor

G J Bhat1, K M Baker

  • 1Pen State University College of Medicine, Weis Center for Research, Danville, PA 17822, USA.

Insights

Angiotensin II (Ang II) delays Stat3 phosphorylation by inducing an inhibitory pathway, unlike IL-6. This Ang II-mediated inhibition of Stat3 activation is reversible and relevant to cardiac hypertrophy and inflammation.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Cardiovascular research

Background:

  • Angiotensin II (Ang II) is a key regulator of cardiovascular function.
  • Signal Transducers and Activators of Transcription (Stat) proteins are crucial in cellular responses.
  • Interleukin-6 (IL-6) is a cytokine involved in inflammation and acute phase responses.

Purpose of the Study:

  • To investigate the mechanism behind Ang II-induced delayed Stat3 tyrosine phosphorylation.
  • To test the hypothesis that Ang II induces an inhibitory pathway before Stat3 activation.
  • To explore the cross-talk between Ang II and IL-6 signaling pathways.

Main Methods:

  • Utilized cultured neonatal rat cardiac fibroblasts and CHO-K1 cells expressing Ang II type 1 receptors (T3CHO/AT1A).
  • Compared Stat3 tyrosine phosphorylation kinetics induced by Ang II versus IL-6.
  • Assessed the effect of Ang II on IL-6-induced Stat3 phosphorylation.
  • Investigated the role of MAP kinase kinase 1 (MAPKK1) using the inhibitor PD98059.

Main Results:

  • Ang II induced a delayed Stat3 tyrosine phosphorylation, peaking at 2 hours, contrasting with IL-6's rapid effect (15-30 min).
  • Short Ang II treatment transiently inhibited IL-6-induced Stat3 tyrosine phosphorylation.
  • The inhibitory effect of Ang II on Stat3 phosphorylation was attenuated by PD98059, suggesting MAPKK1 involvement.

Conclusions:

  • Ang II delays Stat3 activation by inducing a transient inhibitory pathway, likely involving MAPKK1.
  • Modulatory cross-talk between Ang II and IL-6 signaling pathways exists.
  • These interactions may be significant in conditions like cardiac hypertrophy and inflammatory responses.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...